Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Gastroesophageal Reflux 2Zollinger-Ellison Syndrome 1Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Barrett Esophagus 1Appendiceal Neoplasms 1

Interventions

Mitomycin 3Hyperthermic Intraperitoneal Chemotherapy 3Surveys and Questionnaires 2Fluorouracil 2Capecitabine 2tislelizumab 1molgramostim 1irinotecan sucrosofate 1Tacrolimus 1Standard of Care 1Sirolimus 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Oxaliplatin 1Observation 1Methods 1Leucovorin 1Lansoprazole 1Ifosfamide 1Gemcitabine 1Early Intervention, Educational 1Doxorubicin 1Cytoreduction Surgical Procedures 1Clarithromycin 1Cisplatin 1Carboplatin 1Bromelains 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pseudomyxoma Peritonei × Lansoprazole × Clear all
NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡